Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenues
General and administrative costs:    
Compensation to related parties, including stock-based compensation of $339,672 and $656,032 for the three months ended March 31, 2022 and 2021, respectively 565,922 816,032
Patent and licensing legal and filing fees and costs 315,237 120,160
Other 314,743 345,462
Research and development costs 458,450 443,526
Total costs and expenses 1,654,352 1,725,180
Loss from operations (1,654,352) (1,725,180)
Interest income 109 146
Interest expense (2,494) (2,099)
Foreign currency loss (181) (11)
Net loss $ (1,656,918) $ (1,727,144)
Net loss per common share – basic and diluted $ (0.12) $ (0.14)
Weighted average common shares outstanding – basic and diluted 13,746,593 12,768,201